TIMELESS and ovarian cancer: Consistent with the results of colony formation assays in vivo, xenograft experiments showed TIMELESS knockdown could partially reverse the effect of MEX3A overexpression on the growth of ovarian cancer cells in vivo (Fig. 6B).